CR

Chaitanyavenkata Ramakrishna Kalavala

Active Director Director DIN 11182985
DIN 11182985 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chaitanyavenkata Ramakrishna Kalavala

Data last updated:

Chaitanyavenkata Ramakrishna Kalavala is a Director at Metagenix Biolabs Private Limited (since 2025).

DIN 11182985
Primary Designation Director
First Appointment 03 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Metagenix Biolabs Private Limited U21001TS2025PTC200712
Director03 Jul 20252025Active

Board colleagues of Chaitanyavenkata Ramakrishna Kalavala

NameDINCompanyDesignation
Nirmal Kumar Chitta06438972Metagenix Biolabs Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Metagenix Biolabs Private Limited
Premium access

Shareholding and investment profile for Chaitanyavenkata Ramakrishna Kalavala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chaitanyavenkata Ramakrishna Kalavala

Chaitanyavenkata Ramakrishna Kalavala currently holds 1 directorship: Metagenix Biolabs Private Limited (Director, since 03 Jul 2025).

Chaitanyavenkata Ramakrishna Kalavala was first appointed on 03 Jul 2025 as Director at Metagenix Biolabs Private Limited.

The current boards of Chaitanyavenkata Ramakrishna Kalavala's companies include Nirmal Kumar Chitta (Metagenix Biolabs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available